Search details
1.
Subgroup-specific gene expression profiles and mixed epistasis in chronic lymphocytic leukemia.
Haematologica
; 108(10): 2664-2676, 2023 10 01.
Article
in English
| MEDLINE | ID: mdl-37226709
2.
Ibrutinib for improved chimeric antigen receptor T-cell production for chronic lymphocytic leukemia patients.
Int J Cancer
; 148(2): 419-428, 2021 01 15.
Article
in English
| MEDLINE | ID: mdl-32683672
3.
Changes in treatment landscape of relapsed or refractory multiple myeloma and their association with mortality: Insights from German claims database.
Eur J Haematol
; 106(2): 148-157, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-32989806
4.
An Endoplasmic Reticulum Specific Pro-amplifier of Reactive Oxygen Species in Cancer Cells.
Angew Chem Int Ed Engl
; 60(20): 11158-11162, 2021 05 10.
Article
in English
| MEDLINE | ID: mdl-33656236
5.
B-cell maturation antigen-specific chimeric antigen receptor T cells for multiple myeloma: Clinical experience and future perspectives.
Int J Cancer
; 147(8): 2029-2041, 2020 10 15.
Article
in English
| MEDLINE | ID: mdl-32270481
6.
Idelalisib for optimized CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients.
Int J Cancer
; 145(5): 1312-1324, 2019 09 01.
Article
in English
| MEDLINE | ID: mdl-30737788
7.
Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells.
Cancer Immunol Immunother
; 68(7): 1195-1209, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-31177329
8.
Identification of Boronic Acid Derivatives as an Active Form of N-Alkylaminoferrocene-Based Anticancer Prodrugs and Their Radiolabeling with 18F.
Bioconjug Chem
; 30(4): 1077-1086, 2019 04 17.
Article
in English
| MEDLINE | ID: mdl-30768258
9.
Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cells.
Cytotherapy
; 21(5): 566-578, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30910382
10.
Optimizing Manufacturing Protocols of Chimeric Antigen Receptor T Cells for Improved Anticancer Immunotherapy.
Int J Mol Sci
; 20(24)2019 Dec 10.
Article
in English
| MEDLINE | ID: mdl-31835562
11.
Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies.
Int J Mol Sci
; 20(10)2019 May 18.
Article
in English
| MEDLINE | ID: mdl-31109083
12.
ARResT/Interrogate: an interactive immunoprofiler for IG/TR NGS data.
Bioinformatics
; 33(3): 435-437, 2017 02 01.
Article
in English
| MEDLINE | ID: mdl-28172348
13.
MED12 mutations and NOTCH signalling in chronic lymphocytic leukaemia.
Br J Haematol
; 179(3): 421-429, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28771672
14.
Lysosome-Targeting Amplifiers of Reactive Oxygen Species as Anticancer Prodrugs.
Angew Chem Int Ed Engl
; 56(49): 15545-15549, 2017 12 04.
Article
in English
| MEDLINE | ID: mdl-28994179
15.
T-Cell Prolymphocytic Leukemia: Long-Term Remissions Challenging!
Acta Haematol
; 144(1): 4-5, 2021.
Article
in English
| MEDLINE | ID: mdl-32392564
16.
Allogeneic transplantation in high-risk chronic lymphocytic leukemia: a single-center, intent-to-treat analysis.
Haematologica
; 104(7): e304-e306, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30630979
17.
Autologous retransplantation for patients with recurrent multiple myeloma: a single-center experience with 200 patients.
Cancer
; 119(13): 2438-46, 2013 Jul 01.
Article
in English
| MEDLINE | ID: mdl-23576287
18.
Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemia.
Br J Haematol
; 163(4): 496-500, 2013 Nov.
Article
in English
| MEDLINE | ID: mdl-24032483
19.
HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue Sarcoma.
Biomedicines
; 10(2)2022 Feb 03.
Article
in English
| MEDLINE | ID: mdl-35203582
20.
Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells.
Cells
; 10(1)2021 01 14.
Article
in English
| MEDLINE | ID: mdl-33466646